Treating Seizures and Improving Newborn Outcomes for Infants with Hypoxic-Ischemic Encephalopathy.
EEG
Epilepsy
Neurocritical care
Phenobarbital
Seizure
Journal
Clinics in perinatology
ISSN: 1557-9840
Titre abrégé: Clin Perinatol
Pays: United States
ID NLM: 7501306
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
medline:
3
8
2024
pubmed:
3
8
2024
entrez:
2
8
2024
Statut:
ppublish
Résumé
Hypoxic-ischemic encephalopathy is the most common cause of neonatal seizures. Continuous electroencephalographic monitoring is recommended given high rates of subclinical seizures. Prompt diagnosis and treatment of seizures may improve neurodevelopmental outcomes. International League Against Epilepsy guidelines indicate that (1) phenobarbital remains the first-line treatment of neonatal seizures and (2) early discontinuation of antiseizure medications following resolution of acute provoked seizures, and prior to discharge home, is recommended. Long-term follow-up of these infants is necessary to screen for postneonatal epilepsy and support neurodevelopment.
Identifiants
pubmed: 39095097
pii: S0095-5108(24)00052-6
doi: 10.1016/j.clp.2024.04.013
pii:
doi:
Substances chimiques
Anticonvulsants
0
Phenobarbital
YQE403BP4D
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
573-586Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Dr R.A. Shellhaas receives royalties from UpToDate for authorship of topics related to neonatal seizures; serves as a consultant for the Epilepsy Study Consortium; and receives a stipend for her role as president-elect of the Pediatric Epilepsy Research Foundation. Drs H.C. Glass, T. Anwar, R.L. Triplett, and A. Ahmed have nothing to disclose.